Interleukin-4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnover

J Biomed Mater Res A. 2021 Aug;109(8):1512-1520. doi: 10.1002/jbm.a.37142. Epub 2020 Dec 19.

Abstract

Periprosthetic osteolysis remains as a major complication of total joint replacement surgery. Modulation of macrophage polarization with interleukin-4 (IL-4) has emerged as an effective means to limit wear particle-induced osteolysis. The aim of this study was to evaluate the efficacy of local IL-4 delivery in treating preexisting particle-induced osteolysis. To this end, recently established 8 week modification of murine continuous femoral intramedullary particle infusion model was utilized. Subcutaneous infusion pumps were used to deliver polyethylene (PE) particles into mouse distal femur for 4 weeks to induce osteolysis. IL-4 was then added to the particle infusion for another 4 weeks. This delayed IL-4 treatment (IL-4 Del) was compared to IL-4 delivered continuously (IL-4 Cont) with PE particles from the beginning and to the infusion of particles alone for 8 weeks. Both IL-4 treatments were highly effective in preventing and repairing preexisting particle-induced bone loss as assessed by μCT. Immunofluorescence indicated a significant reduction in the number of F4/80 + iNOS + M1 macrophages and increase in the number of F4/80 + CD206 + M2 macrophages with both IL-4 treatments. Reduction in the number of tartrate resistant acid phosphatase + osteoclasts and increase in the amount of alkaline phosphatase (ALP) + osteoblasts was also observed with both IL-4 treatments likely explaining the regeneration of bone in these samples. Interesting, slightly more bone formation and ALP + osteoblasts were seen in the IL-4 Del group than in the IL-4 Cont group although these differences were not statistically significant. The study is a proof of principle that osteolytic lesions can be repaired via modulation of macrophage polarization.

Keywords: interleukin-4; macrophage polarization; murine model; periprosthetic osteolysis; total joint replacement.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Arthroplasty, Replacement / adverse effects
  • Bone Remodeling / drug effects*
  • Interleukin-4 / administration & dosage
  • Interleukin-4 / therapeutic use*
  • Joint Prosthesis / adverse effects*
  • Macrophage Activation / drug effects
  • Macrophages / drug effects
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Osteolysis / drug therapy*
  • Osteolysis / etiology*

Substances

  • Interleukin-4